Join Segmed at ASCO Annual Meeting 2025!

‍

Join us to explore how Segmed can revolutionize your approach to oncology research with Real-World Imaging Data (RWiD) and multimodal datasets, supporting evidence generation across the entire cancer research lifecycle.
‍
At Segmed, we're dedicated to enhancing patient care by integrating RWiD to streamline research and innovation. Our solutions facilitate seamless access to structured, de-identified radiology images and reports, from a diverse population. We helps you harness the full potential of imaging data for:
‍

• clinical trial designing and optimization
• imaging biomarker identification 
• precision medicine
• comparative effectiveness

Our CEO, David Gascoigne and Co-founder, CDO & CRO, Jie Wu, Ph. D., is attending the conference and are eager to connect with you to discuss how Segmed can support your mission to improve patient care.